May 18, 2017 Bio/Pharma/CRO PR/Corporate

Roche presents the first Phase I efficacy and safety data on CEA-TCB (CEA CD3 TCB), a novel T-cell bispecific antibody targeting solid tumours

Basel, 18 May 2017 Roche presents the first Phase I efficacy and safety data on CEA-TCB (CEA CD3 TCB), a novel T-cell bispecific antibody targeting solid tumours Encouraging clinical activity in metastatic colorectal cancer after failure of at least two prior chemotherapy regimens to be presented at the ASCO Annual Meeting Roche (SIX: RO, ROG;... Read more

May 17, 2017 PR/Corporate

Spectris Appoints New Chairman

17 May 2017 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that Mark Williamson has been appointed to the Board as Non-executive Chairman with effect from the conclusion of the Spectris Annual General Meeting (‘AGM’) to be held on 26 May 2017. As previously announced, Dr. John Hughes, Chairman,... Read more

May 16, 2017 Chromatography Mass Spectrometry PR/Corporate

Record-breaking number of visitors for the SCIEX LC-MS/MS Symposium in Berlin

Darmstadt, Germany May 16, 2017 Darmstadt, GERMANY — SCIEX, a global leader in life science analytical technologies, hosted the 7th Berliner LC-MS/ MS Symposium, which took place from 13th-15th March 2017 at the Estrel Hotel in Berlin. The Symposium included a diverse programme of talks from internationally respected researchers and analytical scientists. These covered the... Read more

May 16, 2017 Liq. Handling & Robotics PR/Corporate

Andrew Alliance Awarded Top 100 Most Innovative Companies in Europe- Red Herring

Andrew – The Pipetting Robot – Technology Video AMSTERDAM, May 16, 2017 /PRNewswire/ — Andrew Alliance has been awarded the Red Herring Europe recognition, a prestigious award that positions the company among the top 100 emerging private organizations across all industries on the continent. “In 2017, selecting the top achievers was by no means a small feat,”... Read more

May 15, 2017 Clinical Research/Diagn. PR/Corporate

BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J., May 15, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Bank of America Merrill Lynch 2017 Healthcare Conference  May 17, 2017 11:40 a.m. EDT Jefferies 2017 Global Healthcare Conference June 8, 2017 9:00 a.m.... Read more